Clinical Trial Update: Hypofractionated Protontherapy in Chordomas and Chondrosarcomas of the Skull Base [NA]

View source ↗

Summary

A clinical trial is recruiting to evaluate hypofractionated proton therapy for skull base chordomas and chondrosarcomas.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chondrosarcoma
• Chordoma

Snippet

Sponsor: Quironsalud | Conditions: Chordoma, Chondrosarcoma | NA | Status: RECRUITING